Literature DB >> 20042723

Dengue virus-induced hemorrhage in a nonhuman primate model.

Nattawat Onlamoon1, Sansanee Noisakran, Hui-Mien Hsiao, Alexander Duncan, Francois Villinger, Aftab A Ansari, Guey Chuen Perng.   

Abstract

Lack of a dengue hemorrhagic animal model recapitulating human dengue virus infection has been a significant impediment in advancing our understanding of the early events involved in the pathogenesis of dengue disease. In efforts to address this issue, a group of rhesus macaques were intravenously infected with dengue virus serotype 2 (strain 16 681) at 1 x 10(7) PFU/animal. A classic dengue hemorrhage developed 3 to 5 days after infection in 6 of 6 animals. Blood chemistry appeared to be normal with exception of creatine phosphokinase, which peaked at 7 days after infection. A modest thrombocytopenia and noticeable neutropenia concomitant with slight decrease of hemoglobin and hematocrit were registered. In addition, the concentration of D-dimer was elevated significantly. Viremia peaked at 3 to 5 days after infection followed by an inverse relationship between T and B lymphocytes and a bimodal pattern for platelet-monocytes and platelet-neutrophil aggregates. Dengue virus containing platelets engulfed by monocytes was noted at 8 or 9 days after infection. Thus, rhesus macaques inoculated intravenously with a high dose of dengue virus produced dengue hemorrhage, which may provide a unique platform to define the early events in dengue virus infection and help identify which blood components contribute to the pathogenesis of dengue disease.

Entities:  

Mesh:

Year:  2009        PMID: 20042723      PMCID: PMC2832810          DOI: 10.1182/blood-2009-09-242990

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  52 in total

Review 1.  Dengue fever and dengue haemorrhagic fever--a diagnostic challenge.

Authors:  Sanjaya Senanayake
Journal:  Aust Fam Physician       Date:  2006-08

2.  Possible jungle dengue--recent studies and hypotheses.

Authors:  A Rudnick; N J Marchette; R Garcia
Journal:  Jpn J Med Sci Biol       Date:  1967-12

3.  The correlation between coagulation test and albumin with antithrombin III in Dengue hemorrhagic fever.

Authors:  Joko Budiman Jong; Heridman T Pohan; Iskandar Zulkarnain; Karmel L Tambunan; Marulam M Panggabean; Rahajuningsih D Setiabudy; R H H Nelwan
Journal:  Acta Med Indones       Date:  2004 Apr-Jun

4.  Fibrinogen metabolism and disseminated intravascular coagulation in dengue hemorrhagic fever.

Authors:  T Srichaikul; S Nimmanitaya; N Artchararit; T Siriasawakul; P Sungpeuk
Journal:  Am J Trop Med Hyg       Date:  1977-05       Impact factor: 2.345

5.  Dengue hemorrhagic fever in a British travel guide.

Authors:  Sonja Radakovic-Fijan; Wolfgang Graninger; Christian Müller; Herbert Hönigsmann; Adrian Tanew
Journal:  J Am Acad Dermatol       Date:  2002-03       Impact factor: 11.527

6.  Severe dengue virus infection in travelers: risk factors and laboratory indicators.

Authors:  Ole Wichmann; Joaquim Gascon; Mirjam Schunk; Sabino Puente; Heli Siikamaki; Ida Gjørup; Rogelio Lopez-Velez; Joannes Clerinx; Gabriele Peyerl-Hoffmann; Anders Sundøy; Blaise Genton; Peter Kern; Guido Calleri; Miguel de Górgolas; Nikolai Mühlberger; Tomas Jelinek
Journal:  J Infect Dis       Date:  2007-03-02       Impact factor: 5.226

7.  Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever.

Authors:  Anna P Durbin; Maria José Vargas; Kimberli Wanionek; Samantha N Hammond; Aubree Gordon; Crisanta Rocha; Angel Balmaseda; Eva Harris
Journal:  Virology       Date:  2008-05-02       Impact factor: 3.616

Review 8.  Pathogenesis of dengue: challenges to molecular biology.

Authors:  S B Halstead
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

Review 9.  Platelet-neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation.

Authors:  G Bazzoni; E Dejana; A Del Maschio
Journal:  Haematologica       Date:  1991 Nov-Dec       Impact factor: 9.941

10.  Models of dengue virus infection.

Authors:  Dennis A Bente; Rebeca Rico-Hesse
Journal:  Drug Discov Today Dis Models       Date:  2006
View more
  57 in total

1.  The necessity and quandaries of dengue vaccine development.

Authors:  Stephen J Thomas
Journal:  J Infect Dis       Date:  2011-02-01       Impact factor: 5.226

Review 2.  Dengue epidemiology and pathogenesis: images of the future viewed through a mirror of the past.

Authors:  Rashedul Islam; Mohammed Salahuddin; Md Salahuddin Ayubi; Tahmina Hossain; Apurba Majumder; Andrew W Taylor-Robinson; Abdullah Mahmud-Al-Rafat
Journal:  Virol Sin       Date:  2015-10-20       Impact factor: 4.327

Review 3.  Immune-mediated cytokine storm and its role in severe dengue.

Authors:  Anon Srikiatkhachorn; Anuja Mathew; Alan L Rothman
Journal:  Semin Immunopathol       Date:  2017-04-11       Impact factor: 9.623

4.  Antiviral activity of chloroquine against dengue virus type 2 replication in Aotus monkeys.

Authors:  Kleber Juvenal Silva Farias; Paula Renata Lima Machado; José Augusto Pereira Carneiro Muniz; Aline Amaral Imbeloni; Benedito Antônio Lopes da Fonseca
Journal:  Viral Immunol       Date:  2015-02-09       Impact factor: 2.257

Review 5.  Barriers to preclinical investigations of anti-dengue immunity and dengue pathogenesis.

Authors:  Ashley L St John; Soman N Abraham; Duane J Gubler
Journal:  Nat Rev Microbiol       Date:  2013-05-08       Impact factor: 60.633

6.  The flavivirus dengue induces hypertrophy of white matter astrocytes.

Authors:  Kim M Lee; Kevin B Chiu; Hope A Sansing; Peter J Didier; Andrew A Lackner; Andrew G MacLean
Journal:  J Neurovirol       Date:  2016-06-06       Impact factor: 2.643

7.  Immune Cell Dynamics in Rhesus Macaques Infected with a Brazilian Strain of Zika Virus.

Authors:  Eduardo L V Silveira; Kenneth A Rogers; Sanjeev Gumber; Praveen Amancha; Peng Xiao; Shawna M Woollard; Siddappa N Byrareddy; Mauro Martins Teixeira; Francois Villinger
Journal:  J Immunol       Date:  2017-06-30       Impact factor: 5.422

8.  A Cyclic Phosphoramidate Prodrug of 2'-Deoxy-2'-Fluoro-2'-C-Methylguanosine for the Treatment of Dengue Virus Infection.

Authors:  Ratna Karuna; Fumiaki Yokokawa; Keshi Wang; Jin Zhang; Haoying Xu; Gang Wang; Mei Ding; Wai Ling Chan; Nahdiyah Abdul Ghafar; Andrea Leonardi; Cheah Chen Seh; Peck Gee Seah; Wei Liu; Rao P S Srinivasa; Siew Pheng Lim; Suresh B Lakshminarayana; Ellie Growcott; Sreehari Babu; Martijn Fenaux; Weidong Zhong; Feng Gu; Pei-Yong Shi; Francesca Blasco; Yen-Liang Chen
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

Review 9.  Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus.

Authors:  Kathryn A Hanley; Thomas P Monath; Scott C Weaver; Shannan L Rossi; Rebecca L Richman; Nikos Vasilakis
Journal:  Infect Genet Evol       Date:  2013-03-20       Impact factor: 3.342

10.  A non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 mice.

Authors:  Grace K Tan; Jowin K W Ng; Scott L Trasti; Wouter Schul; George Yip; Sylvie Alonso
Journal:  PLoS Negl Trop Dis       Date:  2010-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.